Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Royalty Pharma plc, 3 years.
Royalty Pharma plc
Director
MSCI Inc.
Director · Chairman and CEO
Chief executive roles
MSCI Inc.
· Chairman and CEO
Dates unknown
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
MSCI Inc. April 21, 202695.4%
-
Royalty Pharma plc May 12, 202599.1%
-
MSCI Inc. April 22, 202594.0%
-
Royalty Pharma plc June 6, 202496.2%
-
MSCI Inc. April 23, 202495.1%
-
Royalty Pharma plc June 22, 202385.3%
-
MSCI Inc. April 25, 202396.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2026 | MSCI Inc. | Open-market purchase | +120 | $559.40 | $67,128 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +240 | $560.28 | $134,467 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +1,238 | $561.56 | $695,211 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +1,122 | $562.47 | $631,091 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +800 | $563.39 | $450,712 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +400 | $564.42 | $225,768 |
| May 15, 2026 | MSCI Inc. | Open-market purchase | +80 | $565.17 | $45,214 |
| Apr 28, 2026 | MSCI Inc. | Gift | −75,707 | — | — |
| Apr 28, 2026 | MSCI Inc. | Gift | +75,707 | — | — |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +240 | $517.32 | $124,157 |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +360 | $519.45 | $187,002 |
| Feb 17, 2026 | MSCI Inc. | Open-market purchase | +200 | $520.00 | $104,000 |
| Feb 13, 2026 | MSCI Inc. | Open-market purchase | +6,000 | $524.18 | $3,145,080 |
| Dec 5, 2025 | MSCI Inc. | Open-market purchase | +360 | $531.98 | $191,513 |
| Dec 5, 2025 | MSCI Inc. | Open-market purchase | +1,124 | $533.12 | $599,227 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.